Figures & data
Table 1. Composition, physical characterization, and release rate kinetics of polycarbophil-based formulations.
Table 2. Composition, physical characterization, and release rate kinetics of carbopol-based formulations.
Figure 1. Release profile of indomethacin from matrix tablets with varying proportions of PCP. Each data point is expressed as mean ± SD (n = 6).
![Figure 1. Release profile of indomethacin from matrix tablets with varying proportions of PCP. Each data point is expressed as mean ± SD (n = 6).](/cms/asset/e3be1d45-8c2d-407a-8ee8-d2ec9377ebe7/idrd_a_382566_f0001_b.gif)
Figure 2. Release profile of indomethacin from matrix tablets with varying proportions of CP. Each data point is expressed as mean ± SD (n = 6).
![Figure 2. Release profile of indomethacin from matrix tablets with varying proportions of CP. Each data point is expressed as mean ± SD (n = 6).](/cms/asset/7bebbef8-08df-4044-8e74-dca26ac422ef/idrd_a_382566_f0002_b.gif)
Figure 3. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 10% PCP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.
![Figure 3. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 10% PCP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.](/cms/asset/ae3ac40e-61bb-4fbc-9807-fb1346d73fa1/idrd_a_382566_f0003_b.gif)
Figure 4. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 20% PCP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.
![Figure 4. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 20% PCP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.](/cms/asset/7c4cbb81-c67e-4d36-9411-16ed74fc4c8f/idrd_a_382566_f0004_b.gif)
Figure 5. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 10% CP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.
![Figure 5. Release profile of indomethacin from matrix tablet showing the effect of varying proportions of EC on 10% CP. Each data point is expressed as mean ± SD (n = 6). The dotted trend line represents the predicted release profile for each formulation beyond 14 h till 24 h.](/cms/asset/24608ab8-d1d7-44b4-9c2d-5fc0d721fe9d/idrd_a_382566_f0005_b.gif)